Our study indicated that high MBL2 serum level is capable of inhibiting the occurrence of double mutation, and alone with other mutations related with HCC, therefore, it can be assumed that high MBL2 may maintain protective effect against HBV-related HCC. This evidence concerns the gene MBL2 and hepatocellular carcinoma.